136 related articles for article (PubMed ID: 19304472)
1. Endothelin receptor blockade in the management of pulmonary arterial hypertension: selective and dual antagonism.
Trow TK; Taichman DB
Respir Med; 2009 Jul; 103(7):951-62. PubMed ID: 19304472
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor antagonism in pulmonary arterial hypertension--a role for selective ET(A) inhibition?
Jacobs A; Preston IR; Gomberg-Maitland M
Curr Med Res Opin; 2006 Dec; 22(12):2567-74. PubMed ID: 17166339
[TBL] [Abstract][Full Text] [Related]
3. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
Iglarz M; Steiner P; Wanner D; Rey M; Hess P; Clozel M
J Cardiovasc Pharmacol; 2015 Oct; 66(4):332-7. PubMed ID: 25992919
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment.
Hall SM; Davie N; Klein N; Haworth SG
Eur Respir J; 2011 Oct; 38(4):851-60. PubMed ID: 21406517
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor antagonists in pulmonary arterial hypertension.
Channick RN; Sitbon O; Barst RJ; Manes A; Rubin LJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):62S-67S. PubMed ID: 15194180
[TBL] [Abstract][Full Text] [Related]
6. The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies.
Davie NJ; Schermuly RT; Weissmann N; Grimminger F; Ghofrani HA
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():38-49. PubMed ID: 19335746
[TBL] [Abstract][Full Text] [Related]
7. The endothelin system in pulmonary arterial hypertension.
Galié N; Manes A; Branzi A
Cardiovasc Res; 2004 Feb; 61(2):227-37. PubMed ID: 14736539
[TBL] [Abstract][Full Text] [Related]
8. Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
Opitz CF; Ewert R
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():1-9. PubMed ID: 16919004
[TBL] [Abstract][Full Text] [Related]
9. Endothelin(A)-endothelin(B) receptor cross-talk and endothelin receptor binding.
Rapoport RM; Zuccarello M
J Pharm Pharmacol; 2011 Nov; 63(11):1373-7. PubMed ID: 21988418
[TBL] [Abstract][Full Text] [Related]
10. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease.
Böhm F; Pernow J
Cardiovasc Res; 2007 Oct; 76(1):8-18. PubMed ID: 17617392
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1-induced pulmonary vasoreactivity is regulated by ET(A) and ET(B) receptor interactions.
Sauvageau S; Thorin E; Caron A; Dupuis J
J Vasc Res; 2007; 44(5):375-81. PubMed ID: 17495482
[TBL] [Abstract][Full Text] [Related]
12. Endothelin(A)-endothelin(B) receptor cross talk in endothelin-1-induced contraction of smooth muscle.
Rapoport RM; Zuccarello M
J Cardiovasc Pharmacol; 2012 Nov; 60(5):483-94. PubMed ID: 22987051
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.
Neuhofer W; Pittrow D
Eur J Clin Invest; 2009 Jun; 39 Suppl 2():50-67. PubMed ID: 19335747
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of endothelin-1-induced pulmonary vasoconstriction following myocardial infarction.
Sauvageau S; Thorin E; Caron A; Dupuis J
Exp Biol Med (Maywood); 2006 Jun; 231(6):840-6. PubMed ID: 16741009
[TBL] [Abstract][Full Text] [Related]
15. Endothelin receptor-mediated vasodilatation: effects of organ culture.
Nilsson D; Wackenfors A; Gustafsson L; Ugander M; Paulsson P; Ingemansson R; Edvinsson L; Malmsjö M
Eur J Pharmacol; 2008 Jan; 579(1-3):233-40. PubMed ID: 17964568
[TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor antagonists in pulmonary arterial hypertension.
Dupuis J; Hoeper MM
Eur Respir J; 2008 Feb; 31(2):407-15. PubMed ID: 18238950
[TBL] [Abstract][Full Text] [Related]
17. Current treatment strategies for pulmonary arterial hypertension.
Lee SH; Rubin LJ
J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
[TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor antagonists.
Clozel M; Maresta A; Humbert M
Handb Exp Pharmacol; 2013; 218():199-227. PubMed ID: 24092342
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.
Maron BA; Zhang YY; White K; Chan SY; Handy DE; Mahoney CE; Loscalzo J; Leopold JA
Circulation; 2012 Aug; 126(8):963-74. PubMed ID: 22787113
[TBL] [Abstract][Full Text] [Related]
20. Endothelin antagonism in pulmonary arterial hypertension.
Lee SH; Channick RN
Semin Respir Crit Care Med; 2005 Aug; 26(4):402-8. PubMed ID: 16121317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
